News
- Author:
- Richard Mark Kirkner
Publish date: April 17, 2024
"Almost half of respondents -- 46% -- reported thinking about their complication for more than 3 hours a day," said study author, Taryn Murray, MD....
News
- Author:
- Richard Mark Kirkner
Publish date: April 10, 2024
“The TELE-ACS protocol provided a significant reduction in readmission rates post-ACS and other adverse events.”
News
- Author:
- Richard Mark Kirkner
Publish date: April 3, 2024
AI agents that aid the existing workforce on specific administrative tasks will be the most likely early use.
News
- Author:
- Richard Mark Kirkner
Publish date: February 29, 2024
Combo treatments or new drug delivery methods may offer patients an alternative or prolonged intervals between injections.
News
- Author:
- Richard Mark Kirkner
Publish date: February 27, 2024
An observational study in the United Kingdom found that patients with RA who started taking antirheumatic drugs had changes in their microbiome aft...
News
- Author:
- Richard Mark Kirkner
Publish date: February 13, 2024
Patients with medication-overuse headache who took prednisolone during medication withdrawal were found to have significantly higher rates of MOH r...
News
- Author:
- Richard Mark Kirkner
Publish date: February 8, 2024
Glaucoma and dry eye treatment options expected to be available for ophthalmologists in 2024.
News
- Author:
- Richard Mark Kirkner
Publish date: January 2, 2024
A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic ...
News
- Author:
- Richard Mark Kirkner
Publish date: December 21, 2023
Wearables, in the form of smartwatches and smartphone connections, are finding their place in monitoring pulmonary disorders, but more innovative r...
News
- Author:
- Richard Mark Kirkner
Publish date: December 18, 2023
A total of 81% of patients who received the iDose TR did not require supplemental drops to reduce IOP after 12 months compared with 95% of those wh...
News
- Author:
- Richard Mark Kirkner
Publish date: December 14, 2023
The extent of this thinning predicts whether kidney function will decline going forward over a period of 2 or 3 years.
News
- Author:
- Richard Mark Kirkner
Publish date: November 28, 2023
Recaticimab, an investigational PCSK9 inhibitor, has shown durable lowering of low-density lipoprotein cholesterol with injection frequencies of 1-...
News
- Author:
- Richard Mark Kirkner
Publish date: November 22, 2023
A pilot study shows that an intervention that gives physicians and patients information on out-of-pocket costs for heart failure drugs can help ens...
News
- Author:
- Richard Mark Kirkner
Publish date: November 20, 2023
The first in-human HEART-1 trial of in vivo DNA editing called VERVE-101, shows reductions in LDL and PCSK9 protein in patients with familial hyper...
News
- Author:
- Richard Mark Kirkner
Publish date: November 16, 2023
An artificial intelligence electrocardiography app cut catheterization lab activation times by 9 minutes in ST-elevation myocardial infarction pati...
